المؤلفون: Valcarcel S; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Avenida Roma Sn., CP 33011, Oviedo, Spain. senavg@gmail.com., Gallego J; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain., Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Diez M; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain., de Castro EM; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Hernandez R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Arrazubi V; Medical Oncology Department, Hospital Universitario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Montes AF; Medical Oncology Department, Complejo Hospitalario Universitario de Ourense, Orense, Spain., Macias I; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Calvo A; Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain., Tocino RV; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca - IBSAL, Salamanca, Spain., Lago NM; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, Coruña, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain., Granja M; Medical Oncology Department, Hospital Universitario Clínico San Carlos Madrid, Madrid, Spain., Gil M; Medical Oncology Department, Hospital General Universitario de Valencia, Ciberonc CB16/12/0035, Valencia, Spain., Pimentel P; Medical Oncology Department, Hospital Santa Lucía, Cartagena, Spain., Macia-Rivas L; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Pérez CH; Medical Oncology Department, Hospital Universitario Nuestra Señora de La Candelaria, Tenerife, Spain., Mangas M; Medical Oncology Department, Hospital Galdakao-Usansolo, Galdakao-Usansolo, Spain., Carnicero AM; Medical Oncology Department, Hospital San Pedro, Logroño, Spain., Cerdà P; Medical Oncology Department, Hospital Santa Creu I Sant Pau, Barcelona, Spain., Gonzalez LG; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., Navalon FG; Medical Oncology Department, Hospital Universitario Son Llatzer, Mallorca, Spain., Rambla MDM; Medical Oncology Department, Hospital Universitario Virgen de La Macarena, Seville, Spain., Richard MM; Medical Oncology Department, Catalan Institute of Oncology (ICO), L'Hospitalet, Spain., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, CP13/00126, PI17/0050 (ISCIII& FEDER), Murcia, Spain.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Jul; Vol. 149 (7), pp. 4077-4089. Date of Electronic Publication: 2022 Aug 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/pathology , Adenocarcinoma*/pathology, Humans ; Paclitaxel ; Antibodies, Monoclonal/therapeutic use ; Registries ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Ramucirumab

SCR Disease Name: Adenocarcinoma Of Esophagus

المؤلفون: Plazas JG; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain. Electronic address: j.gallegoplazas@gmail.com., Arias-Martinez A; Pharmacy Department, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain., Lecumberri A; Medical Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain., Martínez de Castro E; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Hernandez R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Montes AF; Medical Oncology Department, Complejo Hospitalario de Ourense, Ourense, Spain., Macias I; Medical Oncology Department, Hospital Universitario Parc Taulí, Sabadell, Spain., Pieras-Lopez A; Pharmacy Department, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain., Diez M; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Tocino RV; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca - ISBAL, Salamanca, Spain., Lago NM; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, Coruña, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Gil M; Medical Oncology Department, Hospital General Universitario de Valencia - Ciberonc CB16/12/0035, Valencia, Spain., Pimentel P; Medical Oncology Department, Hospital Santa Lucía, Cartagena, Spain., Mangas M; Medical Oncology Department, Hospital Galdakao-Usansolo, Galdakao-Usansolo, Spain., Granja M; Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain., Carnicero AM; Medical Oncology Department, Hospital San Pedro, Logroño, Spain., Pérez CH; Medical Oncology Department, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain., Gonzalez LG; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, Murcia, Spain.

المصدر: ESMO open [ESMO Open] 2022 Jun; Vol. 7 (3), pp. 100514. Date of Electronic Publication: 2022 Jun 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma*/drug therapy , Adenocarcinoma*/epidemiology , Adenocarcinoma*/pathology , Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/epidemiology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Humans ; Male ; Progression-Free Survival ; Registries